ReviewClinical and experimental immunology2019
Immunotherapies based on PD-1/PD-L1 pathway inhibitors in ovarian cancer treatment.
A Pawłowska et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this papercites it